Literature DB >> 8617431

Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.

P Pellinen1, F Stenbäck, A Kojo, P Honkakoski, H V Gelboin, M Pasanen.   

Abstract

The effects of daily cocaine administration for up to 14 days were studied in terms of hepatic morphology and the expression of cytochrome P450 (CYP) enzymes in the mouse liver. Daily intraperitoneal doses of 60 mg/kg of cocaine for 3 days induced severe hepatocellular necrosis in the pericentral zone and decreased activities of CYP1A2, CYP2A4/5, and CYP2Cx. The microsomal CYP2B10 protein content was increased by about 2.5-fold, but 2B10-dependent 7-pentoxyresorufin O-dealkylase (PROD) activity was barely detectable. Five or seven daily cocaine doses caused prominent pericentral inflammation and a significant (up to 14-fold) increase in the microsomal protein content and PROD activity. An increase in microsomal CYP3A was also evident, but CYP2A5 and CYP1A2 still remained at a low level. Immunohistochemical examination showed that the relative induction of CYP2B10 and CYP3A after treatment with cocaine was strongest in perivenous hepatocytes. Immunoinhibition experiments showed that CYP2B10 accounted for catalysis of only 15% to 20% of the enhanced microsomal cocaine N-demethylase (CNDM) activity, which correlated well with immunoreactive 3A protein, and could be blocked 70% to 90% by triacetyloleandomycin. After 10 or 14 daily doses of cocaine, regenerative changes with hepatocyte ballooning were observed, coinciding with increases in CYP1A2, CYP2A4/5, and CYP3A. These results suggest the following: (1) cocaine enhances its own cytochrome P450-dependent metabolism; (2) increased production of norcocaine in microsomes is catalyzed mainly by CYP3A enzyme(s), whereas 2B10, although markedly increased by cocaine treatment, has only a minor role in cocaine hepatotoxicity; and (3) despite increased microsomal CNDM activity, cocaine-induced liver injury is reversible in mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617431     DOI: 10.1002/hep.510230316

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Hyperbaric oxygenation promotes regeneration of biliary cells and improves cholestasis in rats.

Authors:  Akihito Idetsu; Taketoshi Suehiro; Kohji Okada; Tatsuo Shimura; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.

Authors:  Jennifer L Donovan; C Lindsay DeVane; Robert J Malcolm; Jurij Mojsiak; C Nora Chiang; Ahmed Elkashef; Robin M Taylor
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Differential response to IV carfentanil in chronic cocaine users and healthy controls.

Authors:  Carolynne P Minkowski; David Epstein; J James Frost; David A Gorelick
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

Review 4.  Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.

Authors:  Elinore F McCance-Katz
Journal:  Life Sci       Date:  2010-10-19       Impact factor: 5.037

5.  Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.

Authors:  M Cherkaoui-Malki; K Meyer; W Q Cao; N Latruffe; A V Yeldandi; M S Rao; C A Bradfield; J K Reddy
Journal:  Gene Expr       Date:  2001

Review 6.  Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

Authors:  Elinore F McCance-Katz; Lynn E Sullivan; Srikanth Nallani
Journal:  Am J Addict       Date:  2010 Jan-Feb

Review 7.  Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Authors:  Valerie A Gruber; Elinore F McCance-Katz
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

8.  Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

Authors:  Monica Gandhi; Leslie Z Benet; Peter Bacchetti; Ann Kalinowski; Kathryn Anastos; Alan R Wolfe; Mary Young; Mardge Cohen; Howard Minkoff; Stephen J Gange; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.